Skip to main content
. 2020 Jan 9;12(1):163. doi: 10.3390/cancers12010163

Figure 2.

Figure 2

Reported 1-year overall survival (OS) rate for unresectable LAPC across SBRT (●), proton (▲) and carbon (∎) clinical trials compared to 3D conformal chemoradiation () control trial.